|
|
News Breaks | | | | November 5, 2012 | | 08:40 EDT |  | DSCO | Discovery Labs price target lowered to $7.50 from $10 at Roth Capital
Roth Capital reduced its target on Discovery Labs after the company announced a number of commercial delays. However, the firm remains comfortable with the company's business model and expects its stock to advance considerably. The firm maintains a Buy rating on the stock. | |
|
News For DSCO From The Last 14 Days Check below for free stories on DSCO the last two weeks. |
|
|
| May 10, 2013 | | 09:11 EDT |  | DSCO | Discovery Labs 9.5M share Spot Secondary priced at $1.50
 Subscribe for More Information | | | May 9, 2013 | | 18:52 EDT |  | DSCO | On The Fly: After Hours Movers
UP AFTER EARNINGS: Ubiquiti Networks (UBNT), up 11.6%... Unilife (UNIS), up 10.8%... Sequenom (SQNM), up 9.8%. DOWN AFTER EARNINGS: priceline.com (PCLN), down 3.2%... Allscripts (MDRX), down 6.1%... Air Lease (AL), down 10%. ALSO LOWER: Affymax (AFFY), down 11% after disclosing in a regulatory filing that its financial position may prevent it from continuing operations... Discovery Labs (DSCO), down 8.5% after filing to sell common stock... magicJack (CALL), down 6.4% after naming a new CFO. | | | 16:02 EDT | | DSCO | Discovery Labs files to sell common stock, no amount given
Stifel is acting as the sole book-running manager for the offering. | | | May 7, 2013 | | 07:49 EDT |  | DSCO | Discovery Labs reports Q1 EPS (29c), consensus (26c)
Subscribe for More Information | |
|
|
|
|
|
|
